Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease

Histone deacetylases are promising therapeutic targets in hematological malignancies. In the work herein, we investigated the effect of chidamide, a new subtype-selective histone deacetylase inhibitor that was independently produced in China, on multiple myeloma and its associated bone diseases usin...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jingsong, Chen, Qingxiao, Gu, Huiyao, Chen, Jing, Zhang, Enfan, Guo, Xing, Huang, Xi, Yan, Haimeng, He, DongHua, Yang, Yang, Zhao, Yi, Wang, Gang, He, Huang, Yi, Qing, Cai, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068041/
https://www.ncbi.nlm.nih.gov/pubmed/29773595
http://dx.doi.org/10.3324/haematol.2017.181172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068041/
https://www.ncbi.nlm.nih.gov/pubmed/29773595
http://dx.doi.org/10.3324/haematol.2017.181172

Ejemplares similares